At a glance
- Originator Tanabe Seiyaku
- Class Antiplatelets
- Mechanism of Action Calcium channel antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peripheral arterial occlusive disorders